Comparative Benchmarking
In the context of the broader market, RGC competes directly with industry leaders such as ASND and JAZZ. With a market capitalization of $14.48B, it holds a significant position in the sector. When comparing efficiency, RGC's gross margin of N/A stands against ASND's 92.90% and JAZZ's 71.34%. Such benchmarking helps identify whether Regencell Bioscience Holdings Ltd is trading at a premium or discount relative to its financial performance.
